Human tear fluid protects against Pseudomonas aeruginosa keratitis in a murine experimental model

Mary S F Kwong1, David J Evans, Minjian Ni

  • 1School of Optometry, University of California, Berkeley, CA 94720-2020, USA.

Infection and Immunity
|February 28, 2007
PubMed

Insights

Human tear fluid protects against Pseudomonas aeruginosa keratitis in vivo. It reduces infection severity and bacterial colonization by enhancing corneal epithelial barrier function.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Immunology

Background:

  • Pseudomonas aeruginosa keratitis is a severe eye infection.
  • Human tear fluid demonstrated in vitro protection against P. aeruginosa.
  • The protective mechanism in vitro was independent of bacteriostatic activity.

Purpose of the Study:

  • To investigate the in vivo protective effects of human tear fluid against P. aeruginosa corneal infection.
  • To elucidate the mechanisms underlying tear fluid's protective action in vivo.

Main Methods:

  • Tears collected from healthy volunteers were applied to mouse corneas.
  • Infection models involved immediate challenge or challenge during healing after scratch injury.
  • Bacterial colonization and disease severity were assessed at various time points.
  • In vitro assays evaluated bacterial translocation and epithelial barrier function.

Main Results:

  • Human tear fluid reduced disease severity and bacterial colonization in vivo.
  • Complete protection was observed in a model of infection during corneal healing.
  • Tear fluid inhibited bacterial translocation and increased transepithelial resistance in vitro.

Conclusions:

  • Human tear fluid provides significant in vivo protection against P. aeruginosa keratitis.
  • Protection is mediated by enhanced corneal epithelial barrier function and direct effects on bacterial interaction with epithelial cells.